Skip to content
Search

Latest Stories

Why Community Pharmacy Must Embrace Innovation? Insights from Pharmacists

Why Community Pharmacy Must Embrace Innovation? Insights from Pharmacists

Future of community pharmacy: Pharmacists highlight the significance of embracing innovation and collaboration to improve efficiency and patient care

“If we stand still, we will die. We have to keep moving, and we have to keep changing” said Patrick Gompels, co-owner of Gompels Limited, while emphasising the need for innovation in community pharmacy services, during the recent Pharmacy Business Conference 2024.


Centered on the theme 'Pharmacy of Tomorrow,' the conference, held at the Hilton Wembley on April 28, focused on adopting and adapting innovative technology as well as new ways of working and thinking to enhance patient services.

Patrick was joined by Mayank Patel of Pearl Chemist Group and Michael Lennox, CEO of Community Pharmacy Somerset (LPC), during the panel discussion on innovation in community pharmacy services, moderated by Reena Barai, pharmacist and owner of S G Barai Pharmacy.

On the changes he made at Gompels, Patrick said: “The first thing we did was a complete overhaul of all of our systems. Pretty much everything was stripped down.”

He shared that Gompels has embraced innovation by partnering with forward-thinking companies like Titan PMR, Drug Comparison, and Real World Analytics to enhance their processes and data analysis capabilities.

They optimized their dispensary flow, eliminated paper usage, and introduced large dashboards for real-time monitoring of pharmacy operations.

Developing their own booking system and website, Gompels Core, proved to be a significant game changer for them, optimizing pharmacist time and empowering patients to manage their own appointments.

Patrick stated that the adoption of these services has enabled Gompels to decrease flu vaccine appointments from 10 minutes to two within the last three years.

Additionally, they have expanded their team to facilitate 35 Pharmacy First consultations and a full private clinic daily.

“We share all of this data with ICB, LPC and our local GP practices so that we can help bring those numbers up and really push the service,” Patrick added.

Patrick Gompels, co-owner of Gompels Limited, at Pharmacy Business Conference 2024 Patrick Gompels, co-owner of Gompels Limited, at PB Conference 2024

Prioritize safety when adopting new technologies

Mayank Patel shared that the growth of Pearl Chemist Group, currently comprising 26 pharmacies in Southwest London, has been a slow and steady journey because they wanted it to grow effectively.

The group has also embraced technology to enhance work efficiency and patient care. They have implemented two dispensing hubs for compliance packs and pack automation, aiming to free up time for their teams to focus on customer interaction and self-development.

Further, Mayank revealed that they are currently in the process of rolling out a new PMR software, anticipated to be implemented within the coming weeks, and they have established a partnership with an app company to enhance their operational workflows.

However, Mayank underscored the importance of prioritizing safety when adopting new technologies, suggesting that one should find the right partners and evaluate the process thoroughly.

Sharing his approach, he said: “I actually sat back in some of my pharmacies and looked at what the guys were doing and what they were finding hard. And then look into technologies that are right to fix that problem.”

Rather than opting for generic solutions like purchasing a dispensing robot or software, he chose to optimise team capacity and effectiveness through targeted technology integration and training platforms.

Mayank also highlighted the importance of integrating various services to create a seamless patient experience across their online platforms and physical stores.

Mayank Patel of Pearl Chemist Group at recent Pharmacy Business Conference 2024. Mayank Patel of Pearl Chemist Group at PB Conference 2024

The role of LPC networks in leading this change

Michael Lennox highlighted the importance of embracing change and integration within the pharmacy landscape, and the role of LPCs in supporting pharmacists to embrace innovation.

According to him, LPCs are also adapting, adopting and achieving on behalf of contractors, focusing on effective local deployment and delivery of services.

Lennox shared the success story of Somerset, where signup rates and service uptake have gone up drastically, thanks to effective collaboration and innovative approaches, such as introducing new roles like clinical assistants.

He highlighted the importance of having the right platform in place to make processes easier and more efficient for contractors.

SWN10464 Michael Lennox, CEO of Community Pharmacy Somerset (LPC)

The importance of building trust with surgeries

Patrick said that he ensures to visit all local surgeries at least once a week to build trust and strengthen collaboration, and this approach has led to a notable increase in service uptake.

At Gompels, they analyze service usage and trends by extracting data from PharmOutcomes into Excel. They have also partnered with Real World Analytics to automate data publication on a regular basis, enhancing their tracking capabilities.

Patrick added that they share this data with local surgeries, including reasons for referring consultations back and insights gained, fostering mutual learning and trust.

Return on investment is difficult to predict

“It's really hard to work out how much how much you're going to make from each consultation, or every single service that you provide,” Mayank said, advocating for taking calculated risks, such as investing in automation, to understand ROI better.

Nevertheless, he emphasised the importance of effectively communicating the range of services offered, ensuring customer awareness, collaborating with healthcare professionals to enhance service provision, and investing in staff training to achieve long-term benefits.

Mayank also discussed about creating capacity within businesses to accommodate service demands effectively and maintain credibility.

How to encourage more local commission services

Michael suggested that a primary focus for encouraging more local commission services is to execute national services exceptionally well at the local level.

He advises prioritizing the enhancement of national services and existing local services before considering new initiatives.

Expanding on Michael's point, Patrick said that pharmacists should learn to say no to inadequate service offers to drive negotiation for better terms. He shared a successful example from southwest London where rejecting a low-paying smoking cessation service led to increased funding.

In conclusion, the speakers emphasized the importance of knowledge sharing, teamwork and software integration for pharmacy automation to enhance both efficiency and patient care.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less